The revolutionary innovation for treating Atrial Fibrillation (AFib) takes the laser ablation therapies to the new levels in medical technology.
FREMONT, CA: CardioFocus, Inc., a company dedicated to developing innovative and effective electro-physiologist's tools, launches the HeartLight® Endoscopic Ablation System to deliver advanced treatment for AFib. The launched system shows the potential to provide valuable capabilities and unique solutions. The physicians can directly visualize anatomies intra-procedure and precisely target the application of laser energy. The cardiac ablation treatment of atrial fibrillation delivers durable pulmonary vein isolation. The HeartLight System is a third-generation AFib ablation technology to create lines of scar tissue to block the abnormal electrical pathway.
The innovative system is built based on direct tissue visualization, laser energy, and balloon technology. The operation takes place with a continuous and controlled energy delivery for Pulmonary Vein Isolation (PVI). Also, it enables high-powered continuous energy delivery, reducing the time duration with precise calculation.
The new mechanism eliminates the need for manual overlapping for confident isolation and lessens the edema creations. The rapid energy delivery requires less user manipulation, and this overall optimized procedure results in the isolation more efficiently.
Currently, the HeartLight system is available in numerous health care centers across the globe. AFib is suffered by many patients worldwide and often associated with similar symptoms of cognitive decline, heart failure, and functional impairment. In the case of insufficient control over heart arrhythmias with medications, the HeartLight system proves as an effective and safe treatment option.
The advanced technology offered by CardioFocus is a unique RAPID mode featuring a precise motor control system. Enabling the high-speed, uninterrupted, direct assistance by the physicians, the company brings in a revolutionary way of treatment.